Zobrazeno 1 - 10
of 208
pro vyhledávání: '"Karin, Fijnvandraat"'
Autor:
Minka Zivkovic, Elisabeth Pols - van Veen, Vossa van der Vegte, Silvie A.E. Sebastian, Annick S. de Moor, Suzanne J.A. Korporaal, Roger E.G. Schutgens, Rolf T. Urbanus, Erik Beckers, Michiel Coppens, Jeroen Eikenboom, Louise Hooimeijer, Gerard Jansen, Roger Schutgens, Rolf Urbanus, Emile van den Akker, Wala Al Arashi, Ryanne Arisz, Lieke Baas, Ruben Bierings, Maartje van den Biggelaar, Johan Boender, Anske van der Bom, Mettine Bos, Martijn Brands, Annelien Bredenoord, Laura Bukkems, Lex Burdorf, Jessica Del Castillo Alferez, Michael Cloesmeijer, Marjon Cnossen, Mariëtte Driessens, Karin Fijnvandraat, Kathelijn Fischer, Geertje Goedhart, Tine Goedhart, Samantha Gouw, Rieke van der Graaf, Masja de Haas, Lotte Haverman, Jan Hazelzet, Shannon van Hoorn, Elise Huisman, Nathalie Jansen, Alexander Janssen, Sean de Jong, Sjoerd Koopman, Marieke Kruip, Sebastiaan Laan, Frank Leebeek, Nikki van Leeuwen, Hester Lingsma, Moniek de Maat, Ron Mathôt, Felix van der Meer, Karina Meijer, Sander Meijer, Stephan Meijer, Iris van Moort, Caroline Mussert, Hans Kristian Ploos van Amstel, Suzanne Polinder, Diaz Prameyllawati, Simone Reitsma, Eliza Roest, Lorenzo Romano, Saskia Schols, Carin Uyl, Jan Voorberg, Huan Zhang
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102582- (2024)
Background: Glycoprotein (GP)VI is a platelet-specific collagen receptor required for platelet activation during hemostasis. Platelet reactivity toward collagen is routinely assessed during diagnostic workup of platelet disorders. GPVI can be activat
Externí odkaz:
https://doaj.org/article/0ff9e6640dac449daeff9b624d1422ef
Autor:
Ilja Oomen, Amal Abdi, Ricardo M. Camelo, Fábia M.R.A. Callado, Luany E.M. Carvalho, Ilenia L. Calcaterra, Manuel Carcao, Giancarlo Castaman, Jeroen C.J. Eikenboom, Kathelijn Fischer, Vivian K.B. Franco, Martijn W. Heymans, Frank W.G. Leebeek, David Lillicrap, Cláudia S. Lorenzato, Maria Elisa Mancuso, Davide Matino, Matteo N.D. Di Minno, Alex B. Mohseny, Johannes Oldenburg, Suely Meireles Rezende, Georges-Etienne Rivard, Natalia Rydz, Saskia E.M. Schols, Jan Voorberg, Karin Fijnvandraat, Samantha C. Gouw
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102580- (2024)
Background: Inhibitor eradication to restore factor (F)VIII efficacy is the treatment goal for persons with severe hemophilia A (HA) and inhibitors. Immune tolerance induction (ITI) is demanding and successful in about 70% of people. Until now, it ha
Externí odkaz:
https://doaj.org/article/81986c3b0b0948108260f0f7bf03d9f4
Autor:
Jan Blatný, Jan Astermark, Cristina Catarino, Gerry Dolan, Karin Fijnvandraat, Cédric Hermans, Katharina Holstein, Víctor Jiménez-Yuste, Robert Klamroth, Michelle Lavin, Peter J. Lenting, Sébastien Lobet, Maria Elisa Mancuso, Jayashree Motwani, James S. O’Donnell, Christoph Königs
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Over recent decades, management of people with hemophilia (PwH) has been greatly improved by scientific advances that have resulted in a rich and varied therapeutic landscape. Nevertheless, treatment limitations continue to drive innovation, and emer
Externí odkaz:
https://doaj.org/article/49b84b74635547b39a4cb8316ffbb30c
Autor:
Martijn R Brands, Lotte Haverman, Jelmer J Muis, Mariëtte H E Driessens, Stephan Meijer, Felix J M van der Meer, Marianne de Jong, Johanna G van der Bom, Marjon H Cnossen, Karin Fijnvandraat, Samantha C Gouw
Publikováno v:
JMIR Human Factors, Vol 11, p e48359 (2024)
BackgroundTo enable personalized treatment and shared decision-making in chronic care, relevant health information is collected. However, health information is often fragmented across hospital information systems, digital health apps, and questionnai
Externí odkaz:
https://doaj.org/article/7ed4400b56f64fc9980de1011ad6ad83
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/594d17ca3246490e81ebc236eab0fa2b
Autor:
Ilja Oomen, Marieke Verhagen, Mariarosaria Miranda, Peter Allacher, Erik A. M. Beckers, Nicole M. A. Blijlevens, Johanna G. van der Bom, Michiel Coppens, Mariëtte Driessens, Jeroen C. J. Eikenboom, Karin Fijnvandraat, Shermarke Hassan, Waander L. van Heerde, H. Louise Hooimeijer, Joop H. Jansen, Paul Kaijen, Frank W. G. Leebeek, Daniëlle Meijer, Helmut Paul, Sanna R. Rijpma, Frits R. Rosendaal, Cees Smit, Lize F. D. van Vulpen, Jan Voorberg, Saskia E. M. Schols, Samantha C. Gouw
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesAnti-factor VIII (FVIII) antibodies have been reported to exhibit both neutralizing and non-neutralizing characteristics. This is the first study investigating the full spectrum of FVIII-specific antibodies, including non-neutralizing antib
Externí odkaz:
https://doaj.org/article/597ab8aa3a9e45e5a577ea5c89256fc0
Autor:
Caroline Vuong, Kumar Utkarsh, Rebecca Stojancic, Arvind Subramaniam, Olivia Fernandez, Tanvi Banerjee, Daniel M. Abrams, Karin Fijnvandraat, Nirmish Shah
Publikováno v:
Frontiers in Digital Health, Vol 5 (2023)
BackgroundIn sickle cell disease (SCD), unpredictable episodes of acute severe pain, known as vaso-occlusive crises (VOC), disrupt school, work activities and family life and ultimately lead to multiple hospitalizations. The ability to predict VOCs w
Externí odkaz:
https://doaj.org/article/644037667f1a47df99547a0a319f4b71
Autor:
Caroline Vuong, Kumar Utkarsh, Rebecca Stojancic, Arvind Mallikarjunan, Olivia Fernandez, Karin Fijnvandraat, Nirmish Shah
Publikováno v:
HemaSphere, Vol 7, p e6358685 (2023)
Externí odkaz:
https://doaj.org/article/36d5327475074111816e68ef096e2610
Autor:
Marjon H Cnossen, Karin Fijnvandraat, Ron Mathot, Antoine C G Egberts, Rolf T Urbanus, Anouk Donners, Konrad van der Zwet, Ilmar Kruis, Roger Schutgens, Kathelijn Fischer
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction Emicizumab effectively prevents bleeding in people with haemophilia A (PwHA), but is a burden for national healthcare budgets and consequently may limit access. According to the drug label, dosing of emicizumab is based on body weight wi
Externí odkaz:
https://doaj.org/article/f47c9a04101c40b8914e5a78633418b0
Autor:
Martijn R Brands, Samantha C Gouw, Molly Beestrum, Robert M Cronin, Karin Fijnvandraat, Sherif M Badawy
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 12, p e43086 (2022)
BackgroundeHealth tools such as patient portals and personal health records, also known as patient-centered digital health records, can engage and empower individuals with chronic health conditions. Patients who are highly engaged in their care have
Externí odkaz:
https://doaj.org/article/e689dad5cf41487ea3d7b47503203eb7